Patents by Inventor Meena

Meena has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SYSTEM FOR DETECTING FAULTS IN ELECTRICAL WIRING, AND MANUFACTURING METHOD THEREOF
    Publication number: 20110043219
    Abstract: A diagnostic system for detecting faults in electrical wiring, and manufacturing method thereof is provided. The diagnostic system includes a diagnostic sensor coupled to a data acquisition system. The diagnostic sensor includes a sensor housing with a flexible coil sensor disposed inside. The sensor housing includes a base portion, lid portion, and a joining portion, wherein one end of the lid portion is detachably coupled to a first end of the base portion and another end of the lid portion is coupled to a second end of the base portion via the joining portion. The diagnostic sensor further includes a connector coupled to the flexible coil sensor.
    Type: Application
    Filed: October 28, 2010
    Publication date: February 24, 2011
    Applicant: GENERAL ELECTRIC COMPANY
    Inventors: Meena Ganesh, David Mulford Shaddock, Selaka Bandara Bulumulla
  • TECHNIQUES FOR SCHEDULING MEETING RESOURCES IN CALENDAR SYSTEMS
    Publication number: 20110040599
    Abstract: Techniques for scheduling meeting resources within calendar systems are presented. Non-human resources are made available for scheduling within a calendar system. As these meeting resources are identified within the calendar system a background search is performed to determine their availability for a proposed meeting that has not yet been scheduled. The status of availability for the meeting resources are communicated within the calendar system to a meeting organizer.
    Type: Application
    Filed: August 13, 2009
    Publication date: February 17, 2011
    Inventors: Meena Guruprasad, Hema Joshi, Smita R. Talashikar
  • Compounds as cannabinoid receptor ligands and uses thereof
    Patent number: 7875639
    Abstract: The present invention relates to compounds of formula (I), or pharmaceutically acceptable salts, prodrugs, salts of prodrugs, or combinations thereof, wherein R1, R2, R3, R4, and L2, are defined in the specification, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.
    Type: Grant
    Filed: May 31, 2007
    Date of Patent: January 25, 2011
    Assignee: Abbott Laboratories
    Inventors: Alan S. Florjancic, Michael J. Dart, Keith B. Ryther, Arturo Perez-Medrano, William A. Carroll, Meena V. Patel, Karin Rosemarie Tietje, Tongmei Li, Teodozyj Kolasa, Megan E. Gallagher, Sridhar Peddi, Jennifer M. Frost, Derek W. Nelson
  • Compounds as cannabinoid receptor ligands
    Patent number: 7875640
    Abstract: The present application relates to thiazolylidene containing compounds of formula (I) wherein R1, R2, R3, R4, L2 and A are as defined in the specification. Compositions comprising such compounds, and methods for treating conditions and disorders using such compounds and compositions are also disclosed.
    Type: Grant
    Filed: March 19, 2008
    Date of Patent: January 25, 2011
    Assignee: Abbott Laboratories
    Inventors: Teodozyj Kolasa, Jennifer M. Frost, Meena V. Patel, Steven P. Latshaw, Arturo Perez-Medrano, Xueqing Wang, Sridhar Peddi, William A. Carroll, Michael J. Dart
  • Compounds as cannabinoid receptor ligands
    Patent number: 7872033
    Abstract: The present application relates to isothiazolylidene containing compounds of Formula (I) wherein R1, R2, R3, R4, and L are as defined in the specification, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.
    Type: Grant
    Filed: April 10, 2008
    Date of Patent: January 18, 2011
    Assignee: Abbott Laboratories
    Inventors: William A. Carroll, Michael J. Dart, Teodozyj Kolasa, Tongmei Li, Derek W. Nelson, Meena V. Patel, Sridhar Peddi, Arturo Perez-Medrano, Xueqing Wang
  • CONTENT MANAGEMENT APPLICATION FOR AN INTERACTIVE ENVIRONMENT
    Publication number: 20110010442
    Abstract: The content management application is an intranet application which provides a process for implementing changes to an internet website of a company by providing the company the ability to define and enforce a common style of page layout. The application can be accessed via a desktop browser and multiple users may access the application for multiple reasons at the same time. The application also dynamically generates new page designs and new component design with various people assigned to groups or teams enabling the continuous creation and processing of content. Once the content is created and reviewed, it is then launched onto the company's internet site for viewing by the internet users accessing the company's web page.
    Type: Application
    Filed: September 17, 2010
    Publication date: January 13, 2011
    Applicant: American Express Travel Related Services Company, Inc.
    Inventors: Andrea Bimson, Jin Chyung, Meena Gopakumar, Lorraine Miranda, Biswajit Sarkar, Shashikant Rao, Kaustubh Kunte
  • Device simulator framework for an RFID infrastructure
    Patent number: 7868738
    Abstract: The claimed subject matter provides a system and/or a method that facilitates simulating one or more devices respective to disparate vendors, wherein the devices can be associated with an RFID infrastructure. A physical device can wirelessly receive data from a tag. A device simulator can employ a virtual replication of the physical device to simulate the physical device within an RFID network allowing the device to be virtually represented as if physically within the RFID network.
    Type: Grant
    Filed: July 28, 2006
    Date of Patent: January 11, 2011
    Assignee: Microsoft Corporation
    Inventors: Koushik Dasgupta, Bhola R. Meena
  • ZAP-70 AS PREDICTOR AND MODULATOR OF EFFECTOR FUNCTION OF T CELLS
    Publication number: 20100331391
    Abstract: In this application is described a novel, multiparameter analysis of TCR-coupled signaling and function in resting and activated naive and memory CD4 T cells, revealing a biochemical basis for immunological recall. Results reveal a novel biochemical signature imparted to memory CD4 T cells enabling efficacious responses through increased ZAP-70 expression and reduced accumulation of downstream signaling events.
    Type: Application
    Filed: September 10, 2008
    Publication date: December 30, 2010
    Inventors: Meena Chandok, Donna Farber, Francesca Okoye
  • Transferring selected open browser tabs from a host computer to a client computer
    Patent number: 7860956
    Abstract: A method, system, and computer program product for transferring selected open browser tabs from a host computer to a client computer. The method includes copying a selected number of hyperlink addresses from a plurality of hyperlink addresses associated with a plurality of selected open browser tabs in a first browser of the host computer. A hyperlink import module of the client computer is activated for transferring the copied hyperlink addresses from the host computer. Before the transfer can occur, the client computer is authenticated. After authentication, the user of the client computer selects a subset of the copied hyperlink addresses from the host computer. Only the subset of the copied hyperlink addresses is transferred from the host computer to the client computer. The client user opens the subset of the copied hyperlink addresses in a second browser of the client computer for displaying.
    Type: Grant
    Filed: February 5, 2009
    Date of Patent: December 28, 2010
    Assignee: International Business Machines Corporation
    Inventor: Meena Sundararajan
  • COMPOSITIONS COMPRISING NANOPARTICLES AND APOPTOTIC AGENTS AND METHODS OF USE
    Publication number: 20100285138
    Abstract: Compositions comprising nanoparticles, such as silver or gold nanoparticles or carbon nanotubes (CNTs), and apoptotic agents are described. The nanoparticles can significantly enhance the cancer chemotherapeutic effects of the apoptotic agents. In particular, a highly increased anti-tumor activity has been demonstrated for the combination of etoposide and CNTs against HeLa cells compared to the administration of either etoposide alone or nanoparticles alone. Data provided by flow cytometry, Caspase 3 and other methods, suggest a strong interaction between the nanoparticles and the cellular structure, which can result in the improved effectiveness of chemotherapeutic agents. These findings provide potential new cancer therapies by carefully selecting the right combination of cytostatic drugs and nanostructural materials which synergistically provide significantly greater curative rates.
    Type: Application
    Filed: May 6, 2010
    Publication date: November 11, 2010
    Applicant: BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS
    Inventors: Alexandru S. BIRIS, Meena MAHMOOD
  • NOVEL AMIDE AND AMIDINE DERIVATIVES AND USES THEREOF
    Publication number: 20100267738
    Abstract: The present invention relates to inhibitors of 11-?-hydroxysteroid dehydrogenase type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions that are related to excessive glucocorticoids.
    Type: Application
    Filed: April 20, 2010
    Publication date: October 21, 2010
    Applicant: ABBOTT LABORATORIES
    Inventors: Sridhar Peddi, Meena V. Patel, Jeffrey J. Rohde
  • Content management application for an interactive environment
    Patent number: 7818411
    Abstract: The content management application is an intranet application which provides a process for implementing changes to an internet website of a company by providing the company the ability to define and enforce a common style of page layout. The application can be accessed via a desktop browser and multiple users may access the application for multiple reasons at the same time. The application also dynamically generates new page designs and new component design with various people assigned to groups or teams enabling the continuous creation and processing of content. Once the content is created and reviewed, it is then launched onto the company's internet site for viewing by the internet users accessing the company's web page.
    Type: Grant
    Filed: April 21, 2008
    Date of Patent: October 19, 2010
    Assignee: American Express Travel Related Services Company, Inc.
    Inventors: Andrea Bimson, Jin Chyung, Meena Gopakumar, Lorraine Miranda, Biswajit Sarkar, Shashikant Rao, Kaustubh Kunte
  • METHOD AND SYSTEM FOR PASSIVELY DETECTING AND LOCATING WIRE HARNESS DEFECTS
    Publication number: 20100253364
    Abstract: A method and system for detecting defects in a wire or wire harness includes a pair of sensors wrapped around the wire or harness, a data acquisition device for monitoring pulses in the signal produced by the sensors around the wires, and a diagnostics engine. The diagnostics engine includes an analysis module to determine features of the signals captured by the data acquisition device and a decision module for determining whether the pulse represents a defect in the wire, and the location of the defect. The system operates passively and can be used to monitor the wires while they are in use for carrying signals or current and does not require disconnecting the wires to be monitored.
    Type: Application
    Filed: March 14, 2007
    Publication date: October 7, 2010
    Applicant: GENERAL ELECTRIC COMPANY
    Inventor: Meena Ganesh
  • Plant PR-5 proteins as mammalian therapeutic agents
    Patent number: 7803854
    Abstract: The Proteins of the PR-5 family having a lectin-like ? barrel domain control apoptosis in yeast through receptor binding. Receptors that specifically bind to PR-5 proteins having a lectin-like ? barrel domain have been found to be homologous to mammalian adiponectin receptors, and such PR-5 proteins can act as functional homologues of adiponectin and control adiponectin response in mammals. PR-5 proteins having a lectin-like ? barrel domain, for example osmotin, can be used in the treatment of conditions in mammals which are the result of activation or inhibition of adiponectin receptor-mediated metaboloic pathways. PR-5 proteins having a lectin-like ? barrel domain, nucleic acids encoding such proteins, and receptors that specifically bind such proteins, can also be used in screening and rational design of new therapeutic agents for use in mammals.
    Type: Grant
    Filed: December 26, 2007
    Date of Patent: September 28, 2010
    Assignee: Purdue Research Foundation
    Inventors: Ray A. Bressan, Meena L. Narasimhan
  • Plant PR-5 proteins as mammalian therapeutic agents
    Patent number: 7803556
    Abstract: The Proteins of the PR-5 family having a lectin-like ? barrel domain control apoptosis in yeast through receptor binding. Receptors that specifically bind to PR-5 proteins having a lectin-like ? barrel domain have been found to be homologous to mammalian adiponectin receptors, and such PR-5 proteins can act as functional homologues of adiponectin and control adiponectin response in mammals. PR-5 proteins having a lectin-like ? barrel domain, for example osmotin, can be used in the treatment of conditions in mammals which are the result of activation or inhibition of adiponectin receptor-mediated metaboloic pathways. PR-5 proteins having a lectin-like ? barrel domain, nucleic acids encoding such proteins, and receptors that specifically bind such proteins, can also be used in screening and rational design of new therapeutic agents for use in mammals.
    Type: Grant
    Filed: December 26, 2007
    Date of Patent: September 28, 2010
    Assignee: Purdue Research Foundation
    Inventors: Ray A. Bressan, Meena L. Narasimhan
  • NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS
    Publication number: 20100234345
    Abstract: The present application relates to isothiazolylidene containing compounds of Formula (I) wherein R1, R2, R3, R4, and L are as defined in the specification, compositions comprising such compounds, and methods for treating conditions and disorders using such compounds and compositions.
    Type: Application
    Filed: November 4, 2009
    Publication date: September 16, 2010
    Applicant: ABBOTT LABORATORIES
    Inventors: William A. Carroll, Michael J. Dart, Teodozyj Kolasa, Tongmei Li, Derek W. Nelson, Meena V. Patel, Sridhar Peddi, Arturo Perez-Medrano, Xueqing Wang
  • NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS
    Publication number: 20100216760
    Abstract: Disclosed herein are cannabinoid receptor ligands of formula (I) wherein L1, A1, R1g, z, R2, R3, and R4 are as defined in the specification. Compositions comprising such compounds and methods for treating conditions and disorders using such compounds and compositions are also presented.
    Type: Application
    Filed: December 16, 2009
    Publication date: August 26, 2010
    Applicant: ABBOTT LABORATORIES
    Inventors: Jennifer M. Frost, Steven P. Latshaw, Michael J. Dart, William A. Carroll, Arturo Perez-Medrano, Teodozyj Kolasa, Meena V. Patel, Derek W. Nelson, Tongmei Li, Sridhar Peddi, Xueqing Wang, Bo Liu
  • Scarified infused dried buoyant cranberries and method for making same
    Patent number: 7781008
    Abstract: Disclosed is a scarified, whole, dried, infused, buoyant cranberry. Further a process for preparing the cranberry is disclosed. The process includes sizing individually quick frozen cranberries by collecting those that pass through a mesh screen with 16 millimeter openings and that are retained on a mesh screen with openings of 9 millimeters. The sized cranberries are then scarified and infused in an infusion solution having a Brix of from 40 to 80 at a temperature of from 29 to 44° C.±5° C. until the cranberries have a Brix of at least about 40. The cranberries are removed from the infusion solution and dried at a temperature of from 73 to 85° C. until they have a water activity level of from 0.25 to 0.6 and a buoyancy of at least 30%.
    Type: Grant
    Filed: August 7, 2006
    Date of Patent: August 24, 2010
    Assignees: Kellogg Company, Graceland Fruit, Inc.
    Inventors: Nirmal K. Sinha, Meena Sinha, Michael N. Bauman, Chris Willoughby
  • TRANSFERRING SELECTED OPEN BROWSER TABS FROM A HOST COMPUTER TO A CLIENT COMPUTER
    Publication number: 20100198918
    Abstract: A method, system, and computer program product for transferring selected open browser tabs from a host computer to a client computer. The method includes copying a selected number of hyperlink addresses from a plurality of hyperlink addresses associated with a plurality of selected open browser tabs in a first browser of the host computer. A hyperlink import module of the client computer is activated for transferring the copied hyperlink addresses from the host computer. Before the transfer can occur, the client computer is authenticated. After authentication, the user of the client computer selects a subset of the copied hyperlink addresses from the host computer. Only the subset of the copied hyperlink addresses is transferred from the host computer to the client computer. The client user opens the subset of the copied hyperlink addresses in a second browser of the client computer for displaying.
    Type: Application
    Filed: February 5, 2009
    Publication date: August 5, 2010
    Applicant: International Business Machines Corporation
    Inventor: MEENA SUNDARARAJAN
  • Peeled infused dried buoyant cranberries and method for making same
    Patent number: 7767242
    Abstract: Disclosed is a peeled whole dried infused buoyant cranberry. Further a process for preparing the cranberry is disclosed. The process includes sizing individually quick frozen cranberries by collecting those that pass through a mesh screen with 16 millimeter openings and that are retained on a mesh screen with openings of 9 millimeters. The sized cranberries are then peeled and infused in an infusion solution having a Brix of from 40 to 80 at a temperature of from 29 to 44° C.±5° C. until the cranberries have a Brix of at least about 40. The cranberries are removed from the infusion solution and dried at a temperature of from 73 to 85° C. until they have a water activity level of from 0.25 to 0.6 and a buoyancy of at least 30%. The final dried infused cranberry preferably has a Brix of 76 to 84.
    Type: Grant
    Filed: August 7, 2006
    Date of Patent: August 3, 2010
    Assignee: Kellogg Company
    Inventors: Michael N. Bauman, Chris Willoughby, Nirmal K. Sinha, Meena Sinha